|
|
Office Locations:
|
303 Wyman Street, Suite 300
Waltham, MA 02451
Phone: 781-530-3868
Fax: 253-484-4262
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Lumira Ventures invests in transformative biopharmaceutical, medical device and digital health companies located in North America. The firm's history goes back to 1989 when the company was established as MDS Capital Corp. The company changed its name to Lumira Capital in September 2007 as part of a corporate repositioning to build on its strength in the North American health and life science sector. Typically, Lumira's initial investment size is $5 to 10 million, and the firm concentrates its investments in the U.S. and Canada. Over more than two decades, the firm has invested over $1B via multiple investment funds in order 200 healthcare companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
